Remove solutions industry-solutions healthcare-and-pharma
article thumbnail

JAMP Pharma Group acquires a mfg. facility in LĂ©vis, Que.

Canadian Manufacturing

JAMP Pharma Group acquires the manufacturing operations of this plant at a time when governments, customers, and partners are calling for more local procurement solutions. “For several years, healthcare professionals and patients have had to deal with inventory shortages.

article thumbnail

Which Growth Opportunities Are Reshaping the Precision Oncology Landscape?

Frost & Sullivan Manufacturing

Experts, including oncologists, decision-support scientists, and healthcare professionals, are currently navigating the complex process of identifying biomarker correlations based on a patient’s genetic makeup. Note: Gain valuable perspectives from these industry experts by clicking here to access the recorded session of the Think Tank.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Connect in Pharma Promoting New Era of Cross-Sector Collaboration

MEM

The newly announced agenda for Connect in Pharma sends a strong message for more cross-sector collaboration. A recently released report from Connect in Pharma found that pharma lagged behind other sectors when it came to the adoption of digitally-enabled manufacturing techniques. is also due to speak at Connect in Pharma.

article thumbnail

India 2023 Top 5 Trends to Watch Healthcare

Frost & Sullivan Manufacturing

Healthcare sector enjoyed its well-deserved prominence in 2022 with all round operational efficiency, expansion, and digitization gains across pharma, medtech, and delivery. In addition to burgeoning in-house innovation, India’s G20 leadership in 2023 will open new avenues for collaborative growth in the healthcare sector.

article thumbnail

Robotic process automation market projected to reach $70 billion by 2032

Control Engineering

The demand is increasing for robotic process automation in healthcare, as robotic process automation can mimic human interaction. Healthcare providers gather huge amounts of data like personal information of the patient or the treatment cycle of the patient every day. billion in 2022 and is projected to reach $69.20 billion by 2032.

article thumbnail

Right-shoring and Innovation in Oral Dosage Forms Emerge as Top Growth Opportunities for Small Molecule Contract Development & Manufacturing Organizations (CDMO)

Frost & Sullivan Manufacturing

To discuss supply chain issues, recent developments, and innovations in pharmaceutical development, and manufacturing, industry participants shared their strategic viewpoints and growth strategies during DCAT 2023. Managing optimal inventory levels remains vital as CDMOs work on multiple projects simultaneously.

Form 52
article thumbnail

BUDGET 2023-2024 ANALYSIS – Pharma

Frost & Sullivan Manufacturing

Leading domestic pharma companies like Glenmark Pharma are developing and out-licensing new chemical entities (NCEs) and new biological entities (NBEs). Leading domestic pharma companies like Glenmark Pharma are developing and out-licensing new chemical entities (NCEs) and new biological entities (NBEs).